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Introduction
Cancer is a major global health problem and cancer therapy is painful and demanding for patients 1 as nausea, vomiting and loss of hair, and the prolonged systemic distribution causes a dramatic decrease in the quality of life in cancer patients 2 . Because high toxicity limits dose it is impossible to use the full therapeutic potential of anti-cancer drugs. Further, it is difficult to deliver anti-cancer drugs to tumors when they are distributed systemically in its free form; rapid excretion transports the drug out of the body, their often hydrophobic nature results in poor solubility and, finally, free drugs are prone to be metabolized before reaching the target 3 .
As a consequence drugs must be given frequently in multiple rounds to assure drug levels above minimum therapeutic concentration in tumor tissues. Thus, more efficient cancer therapy associated with fewer side-effects is desirable.
The introduction of nanotechnology for cancer therapy has the potential to improve the efficiency of current anti-cancer drugs and quality of life in cancer patients during treatment.
There are at least 23 NP-therapies that are either in clinical use or under clinical investigation 4 . The aim is to deliver anti-cancer drugs encapsulated inside NPs specifically to tumors and thereby increase the drug concentration at target sites and to reduce off-target toxic effects.
Nanotherapies used in the clinic today have the capacity to reduce side-effects but in general they only provide therapeutic efficacy that is comparable to conventional cancer therapy 5, 6 . This suggests that nanomedicine is still in its infancy.
The zebrafish (ZF) model has gained popularity over the past two decades as a model for human diseases, including cancer. This model supports growth of human cancer cell lines that show many similarities to the behavior of tumors in mammalian models such as mice 7, 8 .
Further, when zebrafish are exposed to carcinogens they develop tumors in virtually all organs with similar histology to human tumors 9 . Sequencing of the ZF genome has revealed that 70 % of human genes have at least one ZF orthologue; thus, many of the same molecular and cellular components are involved in the initiation and development of diseases 7, 10 .
Moreover, since the ZF embryo lacks a functional adaptive immune system during its first month of development 11 , this system is increasingly being used to study exogenous human or mouse cancer cells to form tumors as there is no need for active suppression of the immune system to avoid rejection of injected human cells 7, [12] [13] [14] .
An especially valued aspect of the ZF system is that the embryo is optically transparent and tissues can be imaged in detail down to the single cell level, a unique feature for a vertebrate research animal 7 . Consequently, the biggest advantage of this model for cancer research is that tumor growth can be studied by microscopic imaging at high resolution over time in a living organism 15 . This system allows exogenously injected human tumor cell growth and tumor formation to be monitored in real time, with high spatial and temporal resolution. The ZF optical transparency also enables in vivo studies of other fluorescent objects such as NPs. For example, binding of some NPs to endothelial cells has been described as an undesirable characteristic. However, with a few exceptions [16] [17] [18] [19] [20] [21] there has been little analysis of interactions of NPs with endothelial cells in vivo.
Most studies combining nanotechnology and ZF have focused on evaluation of toxicity, by assessing the potential toxic effect that NPs of different chemical composition have on normal development [22] [23] [24] . Regarding nanotherapy, Wagner et al. showed that antibody labeled gold NPs are able to specifically kill cancer cells in the ZF embryo. When heated by a short laser pulse, the gold NPs generated a plasmonic nanobubble which selectively killed the cancer cells 25 . However, in this case the cancer cells were pre-labelled with gold NPs before injection into the ZF embryo. Other studies have shown that NPs do have an effect on growth of cancer cells injected into zebrafish embryos. However, the NPs were introduced via bath-treatment and no evidence was presented to show presence of NPs in tumor-tissues [26] [27] [28] . Our interest here is to use the ZF embryo to facilitate the development of NPs against human cancer that accumulates in tumors after their injection in the circulatory system. We have previously shown that NPs encapsulating an antibiotic are effectively taken up by macrophages in ZF embryos and kill Mycobacterium marinum, the model bacteria for tuberculosis (TB) 29 . An important feature of this TB model-system is that the macrophages that take up the NPs are precisely the same cells where the mycobacteria reside. In stark contrast to TB, NPs for cancer therapy must be fabricated such that they avoid macrophage uptake and thereby stay as long as possible in the circulation to maximize the amount of NPs reaching the tumor. This so-called 'stealth' property of NP's is a major focus of research in all applications of NPs against cancer. The ultimate goal is to develop a so-called "magic bullet"
having features such as the ability to leak out of the vasculature at the tumor site and accumulate in tumor tissues, followed by selective uptake into the cancer cells where the drug is released, thereby killing them [30] [31] [32] [33] .
We introduce the ZF embryo model as a fast screening tool for the development of NP therapies against cancer. Transgenic ZF lines that selectively express fluorescent proteins in selective tissues, for example the vasculature or macrophages, provide highly sophisticated tools for precise and detailed observation of the role of these tissues in development of tumors, as well as a precise tool to evaluate NP biodistribution.
Here we show that coating of NPs with PEG reduces NP adhesion to macrophages in vitro. This effect of PEGylation was also assessed in vivo in the ZF embryo model and it was found that the PEG NPs showed increased circulation time, reduced macrophage uptake, and 35 . The other chemicals, HOBt (1-hydroxybenzotrizole), EDAC
(1-dimethylaminopropyl-ethylcarbodiimide hydrochloride), NHS (N-hydroxysuccinimide), barium hydroxide solution (0.05M) were purchased from Sigma-Aldrich and used without further purification, unless otherwise stated.
For the "brush-like" immobilization of the MPEG5000-NH 2 on the surface of carboxylate microspheres, we adapted a procedure from a previous report by using EDAC in the presence of HOBt in an aqueous solution at 4°C (Scheme 1) 36, 37 . The larger PEGylated particles (0.49µm and 0.997µm) were purified by centrifugation at 10 000 g for 10 min at RT, washed once with 0.01 M HCl and three times with PBS-buffered solution (pH 7.4) via re-dispersion and centrifugation. Finally, the particles were re-suspended in PBS (0.044 wt% for 0.997µm and 0.344 wt% for 0.49µm PEGylation particles) and stored at 4°C until use. The smaller PEGylated NPs (0.19µm) were purified by dialysis, first against distilled water and then against PBS (pH 7.4) at 4 o C for 3 weeks using a dialysis membrane of regenerated cellulose with a molecular weight cut-off of 8000. Finally, the suspension in PBS was stored at 4°C (the concentration: 0.443 wt% for 0.19µm PEGylated NPs) were determined by using UV-Vis photometer (the absorbance of the maximum peak vs particles concentration according to the Beer-Lambert law). Cell debris and dead cells were excluded from analysis based on their forward and side scatter characteristics and at least 10 000 viable cells were analyzed in each group.
ZF injections.
Embryos were injected using a glass needle (Harvard apparatus) controlled with a Narishige MN-153 micromanipulator connected to an Eppendorf FemtoJet express.
Microscopic visualization of the fish during injections was facilitated by a stereomicroscope Leica DFC365FX with a 1.0X Planapo lens.
Cancer cell injections:
Cancer cells were grown in a T25 flask and harvested as described in the cell line section when reaching about 85% confluence. The cell suspension was centrifuged in a 15 ml Falcon tube, washed once with PBS without re-suspending the pellet.
PBS was removed until the pellet was only partially covered and re-suspended in the small remaining PBS. In order to establish the number of cells to be engrafted test injections were done in a drop of water on the lid of a petri dish. The injection pressure or injection time was
adjusted to obtain the desired number of cells per injection. Two dpf embryos were anesthetized with tricaine as described in Gao et al. 39 and 200-300 cancer cells were injected in the lower part of Duct of Cuvier 7 (see Figure 1a ). 24 h post injection embryos were screened for tumor-like structures in the tail.
Nanoparticle injections:
To study nanoparticle behavior in ZF embryos 2 dpf embryos were anesthetized as described above. A glass needle was prepared so that the tip was narrower than the posterior cardinal vein. The injection site for NPs is marked in Figure 1A .
Approximately 3 nl of nanoparticle suspension was injected.
Accumulation of NPs in tumor-like structures:
To study the potential for accumulation of NPs in the tumor-like structures in the tail of ZF embryos, two dpf embryos were injected with cancer cells as described above. Tumor-like structures were allowed to grow for two days and at four dpf, embryos with tumor-like structures in the tail and normal blood flow were injected with NPs. Embryos were anesthetized and inspected for potential accumulation of NPs in the tumor-like structures, using the Leica stereomicroscope, 2-5 h post injection of NPs.
ZF imaging.
A Leica DFC365FX stereomicroscope with a 1.0X Planapo lens was used for quantification of growth of the fluorescent tumor-like structures in ZF embryos. It was also used for imaging of fluorescent NPs in ZF embryos and acquisition of time lapse videos of circulating NPs in ZF embryos. Prior to imaging ZF embryos were anesthetized by adding tricaine to embryo water. Upon imaging embryos were placed on a petri dish on a polymerized 1.5% agarose bed with just enough embryo water to avoid drying the embryo.
All time lapse videos in supplementary data are shown at 7 frames per second.
An Olympus FluoView 1000 upright BX61WI confocal microscope was used for high-resolution microscopic imaging. Prior to imaging embryos were anesthetized in tricaine (Finquel, Argent Laboratories) as described in Gao et al. 39 Subsequently, they were placed in a small dish with a glass bottom filled with low melting point agarose. Once the agarose polymerized, embryo water containing tricaine was added. We used a 40x water objective in Figure 1 and a 60x water objective in Figure 5 and 6. In Supplementary Figure 1 the blue dye Dextran (MW 10 000) was used. 3D view PlugIn in Fiji computer software was used in carefully, to avoid re-suspending the pellet. 0.5mL of PBS was added, and the pellet resuspended. The solution was centrifuged for 15min at 15.000x g for 15min. This washing step was repeated one more time. After the last washing the supernatant was removed, 0.5 mL of PBS added and the pellet was re-suspended. 0.5 mL of the NP-solution was then diluted in 10 mL of PBS in a 50 mL tube, and sonicated for 5 min to make the solution monodisperse.
Before adding the NPs that were incubated with the serum to the cells, the cells were washed three times with 3 mL of PBS to remove residual growth medium. After washing, 2 mL of the NP solution was added to the cells. For the samples where the NPs are not incubated with serum, we followed the same protocol, but only used PBS. After incubation of NPs in serum all analysis of NP adhesion to cells was carried out in PBS to study the effect of the bound serum proteins only.
SEM and TEM imaging. The liposomes were imaged using transmission electron microscopy (TEM) using a Philips CM100. A normal negative stain was applied using 2 % uranyl acetate. The polystyrene NPs were imaged with scanning electron microscopy (SEM) using a Hitachi S-4800. The suspension of NPs was applied to the double-sided carbon tape and air-dried under a lamp for 30min. They were then coated with a 4nm layer of platinum.
Statistics used. The statistics was done using Origin 9.1 software. For the in vitro optical tweezers and growth of the cancer cells after injection the Barnard's Exact test was used to determine p-value, as the data were regarded as binary with regards to adhesion/no adhesion or growth/no-growth, respectively. Significance level is shown as **p<0.01, *p<0.05.
The SE for the binary data was calculated using
, where π=sample proportion of responders. was not observed to be affected by the presence of the tumor-like structure and no endothelial cells were seen to migrate into the tumor mass.
Results and discussion

Establishment
The human embryonic kidney cells (HEK293) were also tested due to their tumorigenicity and ability to establish solid tumors in mice 43, 44 . For these cells, extravasation from the embryo blood vessels was also observed within the first 24 h. A striking characteristic of the HEK 293 cells was the generation of a single, prominent tumor-like structure in the tail of the embryo ( Figure 1E ). The relative location of the HEK293 tumorlike structure to the vasculature was different from the Melmet 5 phenotype, as it was peripheral to the vasculature rather than in between the blood vessels ( Figure 1F -G). Also here, the blood flow was unaffected and no endothelial cells migrated into the tumor-like structure.
Quantifying the growth of the tumor-like structures every second day over a period of six days post-injection ( Figure 1H ) showed that extravasated Melmet 5 cells had an average growth in volume of 84 % from 2 days post injection (dpi) to 6 dpi, with variations among the individuals ranging from 13 % decrease in size to a 162 % increase in size. The HEK293 cells had a lower average growth (34 %), but a much higher degree of variation between embryos from 2 dpi to 6 dpi ranging from a 97 % decrease in size to a 250 % increase in size. Thus, Melmet 5 cells displayed a more consistent potential for sustained growth in the ZF embryo than the HEK293 cells.
The results collectively demonstrate the ability of ZF embryos to support cell survival of our injected human cancer cell lines, and even expansion of the tumor-like structures.
These experiments set the stage for using the ZF embryo as a system for monitoring NPs in a dynamic in vivo vertebrate model for human cancer.
NPs without PEG have short circulation times in vivo. NPs without polyethylene glycol (PEG) coating are known to have short circulation times in vivo as they are more prone to clearance from circulation by macrophages 45 . The transparency of the ZF embryo model offers the possibility of fast, yet detailed in vivo investigation and imaging of the distribution of NPs throughout the organism 29 . By visual inspection using stereomicroscopy, we evaluated the circulation times and biodistribution of both polystyrene nanoparticles (PSNP) and liposomes without PEG (NoPEG) in 2 dpf embryos. We chose to work with these PSNPs as they have a uniform size and their carboxylated surface makes surface modification easy.
The liposomes were included as this type of NPs are already used for therapeutic purposes in the clinic 46 .
In order to study biodistribution and circulation abilities of PSNPs we injected a blue fluorescent version of NoPEG PSNPs (1000 nm) into the circulation of 2 dpf embryos of the showed already a total clearance of liposomes from the circulation. From the injected mpeg cherry embryos it could be concluded that macrophages had cleared the liposomes from the circulation, as multiple yellow dots were visible in the tail, corresponding to the red macrophages filled with green liposomes (Figure 2F, arrows) . Importantly, the liposomes did not adhere to the endothelium and showed no toxicity to the ZF embryos, in stark contrast to the NoPEG PSNPs.
PEG coated NPs display stealth properties in vitro.
The paradigm in the NP field is that PEG adds stealth properties to NPs. The prevailing theory to explain this phenomenon is that this process prevents opsonization by plasma proteins, and thereby macrophage uptake, resulting in prolonged circulation time 5, [48] [49] [50] . To investigate how PEG-coating of NPs affects their interaction with different cell types, we performed incubation studies with cells in vitro.
For this we chose the mouse macrophage RAW cell line which display classic macrophage behavior regarding uptake of foreign particles 51, 52 . The small size of the liposomes excluded them for this type of study.
In these experiments there are three possible outcomes: 1) the OT is not strong enough to remove the NP from the cell, 2) the NP and cell can be moved apart but remain connected through a tether 53 or 3) the particle and cell can be moved apart, since no sufficiently strong adhesion has been made. Here, we classified the tethered particle as 'adhered'. The adhesion percentage was then defined as the number of adhered particles/ total number of experimental attempts at adhesion x 100%.
First, we tested whether the size of the NoPEG PSNPs was proportional to the degree of adhesion. Two sizes of PSNPs with a diameter of 1000 nm and 500 nm (Table 1) were used.
We found that the 1000 nm NoPEG PSNP displayed a significantly higher binding affinity than the 500 nm NoPEG PSNPs ( Figure 4A ). NoPEG 500 nm PSNPs interacted strongly with RAW macrophages (85%) but compared to the 1000 nm particles they had a 10 % reduction in the level of adhesion.
We next investigated whether PEGylation of the PSNPs would result in a lower adhesion to macrophages, as was expected based on our microscopy and flow cytometry experiments. Figure 4B shows snapshots of movies recorded of 1000 nm PSNPs, with or without PEG, pushed against a RAW macrophage. The striking difference is that the NoPEG PSNPs already adhered to the macrophage surface within seconds after the first contact and the macrophage started to engulf it within the first minute ( Figure When quantifying the degree of adhesion and comparing NoPEG vs PEG PSNPs we indeed found that PEG added a measurable stealth effect to PSNPs in vitro. Coating the 1000 nm PSNP with PEG significantly decreased their adhesion to macrophages ( Figure 4C ). A similar decrease in adhesion to macrophages was observed when coating 500 nm PSNPs with PEG. By comparing the degree of adhesion for the 1000 nm and 500 nm PSNPs with PEG coating, the relevance of size for adhesion was eliminated as both the 1000 nm and 500 nm showed similar affinity for the macrophages ( Figure 4C ). Importantly, compared to the NoPEG PSNPs the degree of adhesion of the PEG PSNPs was reduced by 60-70 % ( Figure   4A ).
It is widely believed that the main effect of NP PEGylation in vivo is to reduce the binding of serum proteins and the process of opsonization. In the absence of PEG, serum proteins such as IgG and complement bind to the NPs and allow binding to receptors on the surface of phagocytic cells, such as macrophages [54] [55] [56] . To address the potential role of opsonization by serum proteins we pre-incubated one set of 1000 nm PSNPs with undiluted mouse serum (for mouse macrophages). As controls, two other sets of PSNPs were incubated in either undiluted fetal bovine serum or phosphate-buffered saline (PBS) solution. The further examination of the interactions between NPs and cells was carried out in PBS. All three sets of NoPEG PSNPs were found to have high levels of adhesion to macrophages (above 75%). Conversely, the level of adhesion for PEG PSNPs was below 5% for all three sets ( Figure 4D ). This shows that while PEG lowers the interaction between PSNPs and RAW macrophages, serum had no additional effect on the interactions between NoPEG PSNPs and macrophages.
In a subsequent set of experiments, we determined the adhesion of 1000 nm PSNPs to NPs and bringing them in contact with cells, interaction times and adhesion forces were quantified. We found that the level of adhesion of NP to macrophages depends on the particle size and that PEG coating eliminates this effect. In addition, using this high precision technique we investigated how the presence of serum proteins on the surface of PSNPs influenced their interactions with RAW macrophages and whether PEG had an effect in this system. The classical idea is that PEG prevents opsonization; marking of foreign objects in the blood stream for recognition and uptake by macrophages 57 . Implied in this idea is the fact that in the absence of PEG these serum opsonins are the main factors responsible for Although more detailed studies are needed to make more definitive conclusions, the simplest interpretation of our data in RAW macrophages is that in the absence of PEG on the surface of the PSNP, the particle bind directly to macrophage surface receptors. The PEG molecule directly, rather than indirectly via serum proteins, lowers the interactions between the PSNPs and macrophage surface receptors. By using the optical tweezer to study NP-cell interactions we demonstrate the potential of this method to generate detailed knowledge about how cells interact with NPs with different characteristics.
PEGylation of NPs prolongs in vivo circulation time.
Having demonstrated a clear stealth effect provided by PEG in vitro we next investigated whether this effect could also be observed in the zebrafish, resulting in prolonged NP circulation time in vivo. As described above, NoPEG PSNPs displayed undesirable properties in the ZF embryo, such as short circulation times and a high general affinity for the endothelium as they did not discriminate between the different blood vessels in the tail ( Figure 2C ). We therefore investigated whether PEG could improve the quality of the PSNPs regarding these undesirable properties.
Green fluorescent 200 nm PEG PSNPs (Table 1) were injected in the posterior cardinal vein of 2 dpf wt embryos ( Figure 1A ). 20 seconds post injection these particles were circulating ( Figure 5A , white asterisk, supplementary video 5) and displayed relative low affinity for the endothelium. Further, they only adhered to the small vessels ( Figure 5A , red arrow) in between the caudal artery ( Figure 5A , yellow asterisk) and caudal vein ( Figure 5A , red asterisk). 140 seconds post injection a relatively high amount of PEG PSNPs were still in circulation ( Figure 5B , white asterisk). The PEG PSNPs discriminated between the different blood vessels, as vessels with strong blood flow did not attract PEG PSNPs; they did not adhere to the narrow DLAV vessels ( Figure 5B , white arrow), the caudal artery ( Figure 5B , yellow asterisk) nor the caudal vein ( Figure 5B , red asterisk). Thus, the affinity of the PEG PSNPs was for the most part directed towards the smaller blood vessels ( Figure 5B , red arrow) with natural, weaker blood flow (Supplementary video 6) . The maximum detectable circulation time for PEG PSNPs was about 60 minutes, as evident when the NPs were injected into the Tg(mpeg1:mCherry) UMSF001 zebrafish line. At no time points did the green PEG PSNPs co-localize with the red fluorescent macrophages ( Figure 5C ), suggesting that they are adhered to the endothelium as the circulation time appeared to be too short for the macrophages to be able to take them up.
We next carried out the same experiment with liposomes. The NoPEG version of the liposomes displayed circulation abilities, at first glance compatible with good stealth properties, as they did not attach to the endothelium. However, they were cleared from the circulation long before 20 h post injection by macrophages. Therefore we investigated whether the presence of PEG could delay this process. The addition of PEG to liposomes showed a distinct improvement since they stayed in circulation 24 hours post injection, as observed by the completely visible vasculature in the tail ( Figure 5D, Supplementary Video 7) .
Even though the majority of the PEG liposomes were still circulating it was noteworthy that macrophages had begun to clear PEG liposomes from the circulation, as shown by using the ZF line with red fluorescent macrophages ( Figure 5D , yellow, arrow). By 46 h post injection even more PEG liposomes were taken up by the macrophages ( Figure 5E , green dots, arrows, Supplementary Video 8), but a considerable number of liposomes were still circulating.
Inspection of the embryo by stereomicroscopy 70 h post injection showed a total clearance of PEG liposomes from the blood circulation (Supplementary Video 9), since at this point they were all taken up by macrophages ( Figure 5F , arrow). No liposomes were observed to adhere to the endothelium and importantly, the liposomes were evidently not toxic, as the embryos survived with liposomes present in the circulation for at least 50 h. The PEG molecules need to have a specific morphology and be oriented outwards from the NP surface to be effective.
This morphology is known to change over time and become non-functional, which could explain the eventual uptake of PEG liposomes by macrophages 61 .
Using fluorescent polystyrene nanoparticles and liposomes, we demonstrate that the ZF embryo model makes it possible to follow the NPs from the time of injection up to the point when they are removed from circulation. We could identify two undesirable localization sites in the fish where NPs accumulated: the endothelium and the macrophages. The ability of endothelial cells to bind and to take up NPs has not been studied much in the field of NP therapy against cancer, even though it has been shown in one publication that the vasculature is indeed able to clear foreign objects from circulation in the zebrafish 62 . The association of
NPs with endothelial cells in vivo has been observed in mice 21 , however methods available to routinely visualize NPs in mice may have have precluded identification of their potential binding to blood vessels 17-19, 33, 63-66 . Earlier studies have described binding and uptake of latex particles to sinusoidal endothelial cells after perfusion of rat liver 20 . Thus, adhesion of NPs to the endothelium seems therefore to be a poorly appreciated phenomenon. Drugcontaining NPs that adhere in a non-specific manner to the vasculature will likely have a high probability for toxic side-effects and this interaction must presumably be kept to a minimum.
Tumor vasculature is considered a valid target in cancer therapy 67 and it is possible to target a sub-compartment of the vasculature with NPs
68
. In vitro a considerable uptake of NPs by endothelial cells has been demonstrated and PEGylation of NPs lowers endothelial cell uptake 69 . This is in agreement with our results, which show that PEGylated NPs circulates longer than NPs without PEG and PEGylation was associated with a marked reduction in the endothelial binding of NPs. This shows that the ZF embryo is a highly suitable in vivo model to quickly screen a panel of NPs in the search for candidates with desirable characteristics.
In contrast to endothelium-NP interactions, the undesirable phenomenon of macrophage uptake of NPs from the circulation is well-characterized 70, 71 . In mice, NP . This leads us to speculate that a local activation of endothelial cells in the ZF embryo may lead to a destabilized vasculature.
Whether this effect corresponds to the well-known phenomenon of enhanced permeability and retention (EPR) effect described for mammalian systems remains to be determined 
Conclusions
Here we introduce the ZF embryo and optical tweezers as novel tools for testing novel
NPs aimed for cancer therapy. We present a strategy that can be used to screen for novel anticancer NPs in order to identify leading candidates for subsequent testing in more conventional animal models such as mouse. Undesirable anti-cancer NP properties such as uptake by macrophages and attachment to endothelia are easily and rapidly identified and characterized in ZF embryos. Conversely, the system also allows desirable properties to be monitored, such as NP accumulation in tumor tissues. This in vivo model opens the way for future systematic studies of NPs in dynamic models of human cancer. This will greatly facilitate the search for the most effective materials and surface properties to make NPs for tumor targeting purposes.
In this study, we chose PEG as a model molecule to add stealth properties to NPs as it has been extensively studied and its effects are well known. In accordance with results in the literature, we found that PEG lowers NP uptake by macrophages and increases NP circulation times; moreover, the zebrafish embryo model is sensitive enough to discriminate between PEG-coated and 'naked' NPs. This opens up for testing of more experimental surface coating of NPs in order to identify novel promising candidates for cancer therapy. 
